Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3105088
Max Phase: Preclinical
Molecular Formula: C27H34O5
Molecular Weight: 438.56
Molecule Type: Small molecule
Associated Items:
ID: ALA3105088
Max Phase: Preclinical
Molecular Formula: C27H34O5
Molecular Weight: 438.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1OCc1ccccc1)[C@H]1[C@@H](C[C@H]3C)C1(C)C
Standard InChI: InChI=1S/C27H34O5/c1-15-12-26-16(2)10-20-21(25(20,3)4)19(23(26)30)11-18(13-28)22(29)27(26,31)24(15)32-14-17-8-6-5-7-9-17/h5-9,11-12,16,19-22,24,28-29,31H,10,13-14H2,1-4H3/t16-,19+,20-,21+,22-,24+,26+,27+/m1/s1
Standard InChI Key: BKWJKDPWUAXVGB-WSHSHGDFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 438.56 | Molecular Weight (Monoisotopic): 438.2406 | AlogP: 3.04 | #Rotatable Bonds: 4 |
Polar Surface Area: 86.99 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.16 | CX Basic pKa: | CX LogP: 2.66 | CX LogD: 2.66 |
Aromatic Rings: 1 | Heavy Atoms: 32 | QED Weighted: 0.63 | Np Likeness Score: 2.70 |
1. Grue-Sørensen G, Liang X, Månsson K, Vedsø P, Dahl Sørensen M, Soor A, Stahlhut M, Bertelsen M, Engell KM, Högberg T.. (2014) Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer., 24 (1): [PMID:24332494] [10.1016/j.bmcl.2013.11.073] |
Source(1):